The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.

At Marshfield Children’s Hospital, Dr. Dolly Paw-ton, the facility dog, is helping make them happen. One Wausau family sees ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A panelist discusses recent advancements in bispecific antibody therapies for relapsed/refractory multiple myeloma, ...

DelveInsight's BAFF- and APRIL-targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast ...

Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...

Encephalitis is a medical emergency. Learn the distinct, time-sensitive strategies for treating HSV, West Nile virus, and ...

（编辑推荐）本综述系统阐述自身免疫性大疱病（AIBD）中天疱疮（Pemphigus）和大疱性类天疱疮（BP）的免疫治疗进展。重点解析抗CD20单抗（RTX）在Pemphigus一线治疗中的突破性应用，以及靶向IL-4Rα的度普利尤单抗（Dupilumab）对难治性BP的显著疗效，同时探讨FcRn/BTK ...

GSK’s approval expands belimumab treatment options, offering a first-of-its-kind subcutaneous option that can be administered ...

VIRUDHUNAGAR: After a stray dog allegedly bit nearly 40 people in the last three days in Koomapatti village, residents staged a roadblock on Tuesday, urging the ...

Jankistomig is designed as a dual-pathway, single agent, IgG therapy targeting immune checkpoint inhibition and angiogenesis in the treatment of cancer. The company added Roger Dansey to its board of ...

Argenx (NASDAQ:ARGX) is one of the best biotech stocks to invest in now. On June 20, Argenx announced that the European ...